Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Raimondi

Showing results (351-360 of 399) with videos related to

Pageof 40
Sort By:
Leukemia|July 2, 2015
Ethnic variation of TET2 SNP rs2454206 and association with clinical outcome in childhood AML: a report from the Children's Oncology GroupM A Kutny, T A Alonzo, E R Gamazon, et al.
Cytometry. Part B, Clinical Cytometry|July 12, 2019
Deciphering the Significance of CD56 Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology GroupLaura M Pardo, Andrew P Voigt, Todd A Alonzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2019
Functional Properties of <i>KIT</i> Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid LeukemiaKatherine Tarlock, Todd A Alonzo, Yi-Cheng Wang, et al.
Leukemia|February 24, 2001
Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research HospitalC H Pui, J M Boyett, G K Rivera, et al.
JAMA|October 16, 2003
Results of therapy for acute lymphoblastic leukemia in black and white childrenChing-Hon Pui, John T Sandlund, Deqing Pei, et al.
Transplantation Proceedings|February 23, 2010
The next generation of burns treatment: intelligent films and matrix, controlled enzymatic debridement, and adult stem cellsH Drago, G H Marín, F Sturla, et al.
Leukemia|April 22, 2006
A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignanciesM L Slovak, H Gundacker, C D Bloomfield, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2019
Clofarabine Can Replace Anthracyclines and Etoposide in Remission Induction Therapy for Childhood Acute Myeloid Leukemia: The AML08 Multicenter, Randomized Phase III TrialJeffrey E Rubnitz, Norman J Lacayo, Hiroto Inaba, et al.
Leukemia|December 17, 2009
Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemiaC H Pui, D Pei, J T Sandlund, et al.
British Journal of Haematology|August 29, 2014
Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapySeth E Karol, Elaine Coustan-Smith, Xueyuan Cao, et al.
Pageof 40

Showing results (351-360 of 399) with videos related to

Sort By:
Pageof 40
Leukemia|July 2, 2015
Ethnic variation of TET2 SNP rs2454206 and association with clinical outcome in childhood AML: a report from the Children's Oncology GroupM A Kutny, T A Alonzo, E R Gamazon, et al.
Cytometry. Part B, Clinical Cytometry|July 12, 2019
Deciphering the Significance of CD56 Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology GroupLaura M Pardo, Andrew P Voigt, Todd A Alonzo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2019
Functional Properties of <i>KIT</i> Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid LeukemiaKatherine Tarlock, Todd A Alonzo, Yi-Cheng Wang, et al.
Leukemia|February 24, 2001
Long-term results of Total Therapy studies 11, 12 and 13A for childhood acute lymphoblastic leukemia at St Jude Children's Research HospitalC H Pui, J M Boyett, G K Rivera, et al.
JAMA|October 16, 2003
Results of therapy for acute lymphoblastic leukemia in black and white childrenChing-Hon Pui, John T Sandlund, Deqing Pei, et al.
Transplantation Proceedings|February 23, 2010
The next generation of burns treatment: intelligent films and matrix, controlled enzymatic debridement, and adult stem cellsH Drago, G H Marín, F Sturla, et al.
Leukemia|April 22, 2006
A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignanciesM L Slovak, H Gundacker, C D Bloomfield, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2019
Clofarabine Can Replace Anthracyclines and Etoposide in Remission Induction Therapy for Childhood Acute Myeloid Leukemia: The AML08 Multicenter, Randomized Phase III TrialJeffrey E Rubnitz, Norman J Lacayo, Hiroto Inaba, et al.
Leukemia|December 17, 2009
Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemiaC H Pui, D Pei, J T Sandlund, et al.
British Journal of Haematology|August 29, 2014
Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapySeth E Karol, Elaine Coustan-Smith, Xueyuan Cao, et al.
Pageof 40